HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI.

Abstract
A key step in the Fanconi anemia (FA) tumor suppressor pathway is the site-specific monoubiquitination of the FANCD2 protein. Genetic studies indicate that this crucial modification requires eight known FA gene products and the E2-conjugating enzyme Ube2t. Here, we minimally reconstitute this monoubiquitination reaction with Ube2t and the FANCL protein, revealing that monoubiquitination is stimulated by a conserved RWD-like domain in FANCL. Furthermore, addition of the FANCI protein enhances monoubiquitination and also restricts it to the in vivo substrate lysine residue on FANCD2. This work therefore establishes a system that provides mechanistic insight into the functions of FANCL and FANCI in the catalysis of FANCD2 monoubiquitination.
AuthorsArno F Alpi, Paul E Pace, M Madan Babu, Ketan J Patel
JournalMolecular cell (Mol Cell) Vol. 32 Issue 6 Pg. 767-77 (Dec 26 2008) ISSN: 1097-4164 [Electronic] United States
PMID19111657 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • FANCI protein, human
  • Fanconi Anemia Complementation Group D2 Protein
  • Fanconi Anemia Complementation Group Proteins
  • UBE2T protein, human
  • UBE2W protein, human
  • Ubiquitin-Conjugating Enzymes
  • Fanconi Anemia Complementation Group L Protein
Topics
  • Amino Acid Sequence
  • Animals
  • Cell Line
  • Chickens
  • Conserved Sequence
  • Fanconi Anemia Complementation Group D2 Protein (metabolism)
  • Fanconi Anemia Complementation Group L Protein (chemistry, metabolism)
  • Fanconi Anemia Complementation Group Proteins (metabolism)
  • Humans
  • Molecular Sequence Data
  • Protein Structure, Tertiary
  • Substrate Specificity
  • Ubiquitin-Conjugating Enzymes (metabolism)
  • Ubiquitination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: